Guillaume Dalmasso

Dr. Guillaume Dalmasso

University of Clermont-Auvergne, France
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in Autophagy
Verified
Journal Article
Closed access
DKDaniel J. Klionsky
Daniel J. Klionsky
AAAmal Kamal Abdel-Aziz
Amal Kamal Abdel-Aziz
SASara Abdelfatah
Sara Abdelfatah
MAMahmoud Abdellatif
Mahmoud Abdellatif
AAAsghar Abdoli
Asghar Abdoli
CTChun-Kit Tong
Chun-Kit Tong

27 February 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CPCayetano Pleguezuelos-Manzano
Cayetano Pleguezuelos-Manzano
JPJens Puschhof
Jens Puschhof
AHAxel Rosendahl Huber
Axel Rosendahl Huber
AHArne Van Hoeck
Arne Van Hoeck
HWHenry M Wood
Henry M Wood
Hans CleversHans Clevers
Hans Clevers

10 October 2010 in Nature Materials
Verified
Journal Article
Closed access
PDF file
DWD. Scott Wilson
D. Scott Wilson
GDGuillaume Dalmasso
Guillaume Dalmasso
LWLixin Wang
Lixin Wang
SSShanthi V. Sitaraman
Shanthi V. Sitaraman
DMDidier Merlin
Didier Merlin
NMNiren Murthy
Niren Murthy

21 March 2014 in Gut
Verified
Journal Article
Closed access
PDF file
ACAntony Cougnoux
Antony Cougnoux
GDGuillaume Dalmasso
Guillaume Dalmasso
RMRuben Martinez
Ruben Martinez
EBEmmanuel Buc
Emmanuel Buc
JDJulien Delmas
Julien Delmas
RBRichard Bonnet
Richard Bonnet
Background: Escherichia coli strains harbouring the pks island ( pks + E. coli ) are often seen in human colorectal tumours and have a carcinogenic effect independent of inflammation in an AOM/IL-10 −/− (azoxymethane/interleukin) mouse model. Objective: To investigate the mechanism sustaining pks + E. coli -induced carcinogenesis. Method: Underlying cell processes were investigated in vitro and in vivo (xenograft model) using intestinal epithelial cells infected by pks + E. coli or by an isogenic mutant defective for pks ( pks − E. coli ). The results were supported by data obtained from an AOM/DSS (azoxymethane/dextran sodium sulphate) colon cancer mouse model and from human colon cancer biopsy specimens colonised by pks + E. coli or pks− E. coli . Results: Colibactin-producing E. coli enhanced tumour growth in both xenograft and AOM/DSS models. Growth was sustained by cellular senescence (a direct consequence of small ubiquitin-like modifier (SUMO)-conjugated p53 accumulation), which was accompanied by the production of hepatocyte growth factor (HGF). The underlying mechanisms involve microRNA-20a-5p, which targets SENP1, a key protein regulating p53 deSUMOylation. These results are consistent with the expression of SENP1, microRNA-20a-5p, HGF and phosphorylation of HGF receptor found in human and mouse colon cancers colonised by pks + E. coli . Conclusion: These data reveal a new paradigm for carcinogenesis, in which colibactin-induced senescence has an important role.

29 June 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YYYutao Yan
Yutao Yan
VKVasantha Kolachala
Vasantha Kolachala
GDGuillaume Dalmasso
Guillaume Dalmasso
HNHang Nguyen
Hang Nguyen
HLHamed Laroui
Hamed Laroui
DMDidier Merlin
Didier Merlin
Inflammatory bowel diseases (IBD), including mainly ulcerative colitis (UC) and Crohn's disease (CD), are inflammatory disorders of the gastrointestinal tract caused by an interplay of genetic and environmental factors. Murine colitis model induced by Dextran Sulfate Sodium (DSS) is an animal model of IBD that is commonly used to address the pathogenesis of IBD as well as to test efficacy of therapies. In this study we systematically analyzed clinical parameters, histological changes, intestinal barrier properties and cytokine profile during the colitic and recovery phase. C57BL/6 mice were administered with 3.5% of DSS in drinking water for various times. Clinical and histological features were determined using standard criteria. Myeloperoxidase (MPO) activity, transepithelial permeability and proinflammatory mediators were determined in whole colon or proximal and distal parts of colon. As expected after administration of DSS, mice manifest loss of body weight, shortening of colon length and bloody feces. Histological manifestations included shortening and loss of crypts, infiltration of lymphocytes and neutrophil, symptoms attenuated after DSS withdrawal. The MPO value, as inflammation indicator, also increases significantly at all periods of DSS treatment, and even after DSS withdrawal, it still held at very high levels. Trans-mucosal permeability increased during DSS treatment, but recovered to almost control level after DSS withdrawal. The production of proinflammatory mediators by colonic mucosa were enhanced during DSS treatment, and then recovered to pre-treated level after DSS withdrawal. Finally, enhanced expression of proinflammatory mediators also revealed a different profile feature in proximal and distal parts of the colon. Experimental colitis induced by DSS is a good animal model to study the mechanisms underlying the pathogenesis and intervention against IBD, especially UC.

3 September 2014 in Gut Microbes
Verified
Journal Article
Closed access
GDGuillaume Dalmasso
Guillaume Dalmasso
ACAntony Cougnoux
Antony Cougnoux
JDJulien Delmas
Julien Delmas
ADArlette Darfeuille-Michaud
Arlette Darfeuille-Michaud
RBRichard Bonnet
Richard Bonnet
The gut microbiota is suspected to promote colorectal cancer (CRC). Escherichia coli are more frequently found in CCR biopsies than in healthy mucosa; furthermore, the majority of mucosa-associated E. coli isolated from CCR harbors the pks genomic island (pks+ E. coli) that is responsible for the synthesis of colibactin, a genotoxic compound. We have recently reported that transient contact of a few malignant cells with colibactin-producing E. coli increases tumor growth in a xenograft mouse model. Growth is sustained by cellular senescence that is accompanied by the production of growth factors. We demonstrated that cellular senescence is a consequence of the pks+ E. coli-induced alteration of p53 SUMOylation, an essential post-translational modification in eukaryotic cells. The underlying mechanisms for this process involve the induction of miR-20a-5p expression, which targets SENP1, a key protein in the regulation of the SUMOylation process. These results are consistent with the expression of S...